These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24798712)

  • 41. Clomethiazole treatment of alcohol withdrawal delirium in a patient under methadone maintenance.
    Gross A; Soyka M
    Pharmacopsychiatry; 1996 Nov; 29(6):229-30. PubMed ID: 8956355
    [No Abstract]   [Full Text] [Related]  

  • 42. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Opiate addiction as a chronic brain disease: new concept of an old problem, and re-evaluation of methadone treatment].
    Bleich A; Adelson M
    Harefuah; 2000 Mar; 138(6):454-7. PubMed ID: 10883159
    [No Abstract]   [Full Text] [Related]  

  • 44. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Better efficacy of buprenorphine and methadone in opioid dependence. Requirements for abstinence from non-opioids before starting treatment paid off].
    Hoffmann O; Frisell F; Ljungberg T
    Lakartidningen; 2014 Jan 29-Feb 4; 111(5):147-9. PubMed ID: 24624763
    [No Abstract]   [Full Text] [Related]  

  • 46. Main reasons for hospital admissions by women with a history of methadone maintenance.
    Burns L; Conroy E; Mattick RP
    Drug Alcohol Rev; 2010 Nov; 29(6):669-75. PubMed ID: 20973853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pills for speedballing or cocaine dependence.
    Johnson BA
    Lancet; 2006 May; 367(9524):1714-6. PubMed ID: 16731254
    [No Abstract]   [Full Text] [Related]  

  • 48. A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients.
    Margolin A; Kantak K; Copenhaver M; Avants SK
    J Addict Dis; 2003; 22(2):49-61. PubMed ID: 12703668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern.
    Alammehrjerdi Z; Ezard N; Dolan K
    Asian J Psychiatr; 2018 Jan; 31():49-55. PubMed ID: 29414387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction.
    Peles E; Schreiber S; Bloch M; Dollberg S; Adelson M
    J Addict Med; 2012 Mar; 6(1):18-23. PubMed ID: 21817914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Managing opioid dependence in pregnancy -- a general practice perspective.
    Arunogiri S; Foo L; Frei M; Lubman DI
    Aust Fam Physician; 2013 Oct; 42(10):713-6. PubMed ID: 24130973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
    Peles E; Schreiber S; Rados V; Adelson M
    J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy of L-methadone and racemic methadone in substitution treatment for opiate addicts--a double-blind comparison.
    Scherbaum N; Finkbeiner T; Leifert K; Gastpar M
    Pharmacopsychiatry; 1996 Nov; 29(6):212-5. PubMed ID: 8956350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of opiate dependent drug misusers. Glasgow model should be replicated in other general practices.
    Byrne A
    BMJ; 1997 Sep; 315(7108):602-3. PubMed ID: 9302968
    [No Abstract]   [Full Text] [Related]  

  • 55. New formulation of methadone for opioid dependence in France: acceptability and diversion/misuse liability.
    Eiden C; Léglise Y; Bertomeu L; Clavel V; Faillie JL; Petit P; Peyrière H
    Therapie; 2013; 68(2):107-11. PubMed ID: 23773351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Harm reduction program use, psychopathology and medical severity in patients with methadone maintenance treatment.
    Martínez-Luna NG; Rodríguez-Cintas L; Esojo A; Palma-Álvarez RF; Robles-Martínez M; Grau-López L; Perea M; Roncero C
    Adicciones; 2018 Jan; 30(3):197-207. PubMed ID: 29353292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rifampicin reduces methadone concentrations.
    Dedicoat MJ
    BMJ; 2012 Jun; 344():e4199. PubMed ID: 22718900
    [No Abstract]   [Full Text] [Related]  

  • 58. [Preliminary investigation on the long-term follow-up by the general practitioner of patients receiving methadone maintenance].
    Messaadi N; Barjaud M; Cottencin O
    Presse Med; 2010 Jun; 39(6):722-3. PubMed ID: 20444572
    [No Abstract]   [Full Text] [Related]  

  • 59. Opioid dependence - management in general practice.
    Frei M
    Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Walking through mud; history of the Polish methadone maintenance treatment from its stakeholders' perspective.
    Moskalewicz J; Welbel M
    Subst Use Misuse; 2013 Aug; 48(11):977-96. PubMed ID: 23952510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.